Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia

Published:2011-10-24 Issue:12 Volume:52 Page:2321-2328
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Eom Ki-Seong,Kim Hee-Je,Cho Byung-Sik,Choi Su-Mi,Lee Dong-Gun,Lee Seung-Eun,Yahng Seung-Ah,Kim Yoo-Jin,Lee Seok,Min Chang-Ki,Cho Seok-Goo,Kim Dong-Wook,Lee Jong-Wook,Park Chong-Won,Min Woo-Sung

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.587562

Reference26 articles.

1. Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

2. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461

3. Age and acute myeloid leukemia

4. Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cells

5. Long-term Outcome of Autologous Transplantation of Peripheral Blood Progenitor Cells as Postremission Management of Patients ≥60 Years with Acute Myelogenous Leukemia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients;Annals of Hematology;2023-02-16

2. New agents in acute myeloid leukemia (AML);BLOOD RESEARCH;2020-07-31

3. Characteristics and Clinical Evolution of Patients with Acute Myeloblastic Leukemia in Northeast Mexico: An Eight-Year Experience at a University Hospital;Acta Haematologica;2014

4. How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML;Blood Research;2014

5. Outcomes of elderly de novo acute myeloid leukemia treated by a risk‐adapted approach based on age, comorbidity, and performance status;American Journal of Hematology;2013-09-12